Latin America Pharma Growth: Boehringer Ingelhe...

By HEOR Staff Writer

January 27, 2026

Latin America Pharma Growth is surging as a high-growth engine for Boehringer Ingelheim, with double-digit market expansions outpacing mature regions like Europe, according to
NICE Endorses Dupilumab for Eosinophilic COPD Treatment
Accelerating FAST-EU Clinical Trials
NICE Endorses Talazoparib Enzalutamide for Prostate Cancer Treatment
Sandoz Biosimilars Strategy: Capturing Market Opportunities for Affordable He...
Trump Economic Revival: Key Policies and Impacts from Davos 2026
Long-Term Benefits of Composite Treatment Targets in Type 2 Diabetes Management
Navigating Economic Resilience Through Life Sciences Investment
Guiding Principles for Ethical AI Integration in Drug Development
Obesity Medication Guidelines: Evidence-Based Approaches to Effective Treatment
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...